secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001628280-26-013277
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLife Solutions issues routine investor presentation; no material news disclosed
--------------------------------------------------------------------------------

- Investor presentation released on March 2, 2026, highlights cell-based therapy solutions.
- Presentation available at company's investor relations website.
- No financial results, guidance changes, or strategic initiatives included in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000162828026013277/0001628280-26-013277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000162828026013277/blfs-20260302.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-013277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer